Canadian Sec - Delayed Quote CAD
Quantum BioPharma Ltd. (QNTM.CN)
9.85
+0.35
+(3.68%)
At close: April 25 at 2:16:48 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
15,884.03
15,884.03
19,570.11
27,429.61
33,743.66
Operating Income
-15,884.03
-15,884.03
-19,570.11
-27,429.61
-33,743.66
Net Non Operating Interest Income Expense
525.31
525.31
786.06
318.91
-68.11
Other Income Expense
443.19
443.19
553.46
407.04
-126.18
Pretax Income
-14,915.53
-14,915.53
-18,230.59
-26,703.66
-33,937.96
Net Income Common Stockholders
-14,202.72
-14,202.72
-17,902.18
-23,606.83
-35,285.43
Diluted NI Available to Com Stockholders
-14,202.72
-14,202.72
-17,902.18
-23,606.83
-35,285.43
Basic EPS
-13.19
-13.12
-29.93
-39.61
-65.65
Diluted EPS
-13.19
-13.12
-29.93
-39.61
-65.65
Basic Average Shares
792.88
1,136.92
609.06
595.88
537.62
Diluted Average Shares
792.88
1,136.92
609.06
595.88
537.62
Total Operating Income as Reported
-16,136.26
-16,136.26
-23,789.50
-27,429.61
-33,743.66
Total Expenses
15,884.03
15,884.03
19,570.11
27,429.61
33,743.66
Net Income from Continuing & Discontinued Operation
-14,202.72
-14,202.72
-17,902.18
-23,606.83
-35,285.43
Normalized Income
-14,641.93
-14,641.93
-13,516.63
-26,991.25
-33,761.98
Interest Income
572.89
572.89
786.36
367.74
1.29
Interest Expense
47.58
47.58
0.30
48.82
69.40
Net Interest Income
525.31
525.31
786.06
318.91
-68.11
EBIT
-14,867.95
-14,867.95
-18,230.29
-26,654.84
-33,868.55
EBITDA
-14,377.38
-14,377.38
-15,723.97
-22,117.43
-29,823.03
Reconciled Depreciation
490.57
490.57
2,506.32
4,534.59
4,045.52
Net Income from Continuing Operation Net Minority Interest
-14,202.72
-14,202.72
-17,902.18
-26,703.66
-33,937.96
Total Unusual Items Excluding Goodwill
439.20
439.20
-4,385.55
287.58
-175.98
Total Unusual Items
439.20
439.20
-4,385.55
287.58
-175.98
Normalized EBITDA
-14,816.58
-14,816.58
-11,338.42
-22,405.01
-29,647.05
12/31/2021 - 5/29/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AGFAF Digicann Ventures Inc.
0.0155
0.00%
DCNN.CN Digicann Ventures Inc.
0.0200
0.00%
AUSA.CN Australis Capital Inc.
0.0250
0.00%
VM.V Voyageur Pharmaceuticals Ltd.
0.1750
0.00%
TRUFF Red Light Holland Corp.
0.0240
0.00%
ANIK Anika Therapeutics, Inc.
14.43
+0.38%
OILS.CN Nextleaf Solutions Ltd.
0.0550
+10.00%
KGKG Kona Gold Beverage, Inc.
0.0002
0.00%
CTOR Citius Oncology, Inc.
0.7290
+13.73%
CVSI CV Sciences, Inc.
0.0300
+5.26%